Search results for: 'pfa pharmaceutical'

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...

30 Aug 2022  |  North America  |  Market Outlook

Canada and US Water and Wastewater Outlook, 2022

Growth Strategies will Focus on Adapting to Climate Change, Updating Infrastructure, and Dealing with Emerging Pollutants

Infographics

×

This research study discusses the impact of the pandemic on the water and wastewater industry in the United States and Canada, examining the measures being taken by utilities to deal with the same. It identifies the key trends emerging in the industry and the top utilities to watch out for The COVID-19 pandemic highlighted the importance of having...

Biomarker Analytics has always been one of the most in-demand branches of science relevant to the process of drug discovery and development in the Pharmaceutical Industry. Over the years several advances have been made in the area of biomarker analytics with the aim to accelerate the drug development process. The use of AI-based technology can incr...

05 Feb 2021  |  North America  |  Market Research

Shifting Spotlight from Product- to Value-based Outcomes Intensifies Growth in the US Real-world Evidence IT Solutions Market

Early-stage R&D and Commercial Applications Fuel the Growth Pipeline

Infographics

×

The US healthcare industrys transition to a patient-centric model is moving rapidly with focus on outcomes and value; however, drug prices have increased and pharmaceutical research and development (R&D) productivity is at its lowest. The healthcare industry and IT solutions providers are finding real-world evidence (RWE) as a potential solution to...

Despite the term patient centricity gaining currency in the industry, there is a degree of variability in a companies’ approach and strategic priorities. Frost & Sullivan sees digitization playing a critical role in transforming the clinical trial model from traditional, high-cost, and difficult-to-access centralized settings to more patient-centri...

This research service analyzes current and future trends in the global pumps market across various industries. This analysis is in an Excel format. Analysis has been based on the key end-user segments of pumps (Oil and Gas, chemicals, Power generation, Construction, pharmaceuticals, Food and beverage, Metals and mining, water and wastewater, and ot...

Although the Internet of Things (IoT) has been a buzzword for a long time, its penetration in the analytical instrumentation market has been limited when compared to other industrial markets. With key end users in the pharmaceuticals, food and beverage, and government sectors, the market proceeds with great caution (in terms of technology) as it de...

27 Nov 2019  |  North America  |  Market Research

North American Positive Displacement Pumps Market, Forecast to 2026

Aggressive Oil and Gas Investments in the United States will Drive Long-term Growth Against the Backdrop of Economic Uncertainty

Infographics

×

Key Issues Addressed

The objective of this research service is to identify, analyze, and evaluate current and future trends that impact the North American positive displacement (PD) pumps market. Market dynamics continue to remain cyclical with the prevalence of volatile economic conditions and process industries such as oil and gas and chemicals continuing to invest i...

The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...